Katja van den Hurk: Using Mean Hemoglobin to Improve Donor Eligibility
Katja van den Hurk, Head of Donor Studies at Sanquin, reposted from Amber Meulenbeld on LinkedIn:
”Excited to share our latest work on an alternative deferral algorithm based on mean haemoglobin (Hb) levels), a first step toward a more comprehensive and data-driven assessment of donor eligibility.
Our findings suggest that using historical mean Hb to guide donor deferral decisions could reduce Hb deferral rates and may also help to prevent donations from donors with consistently low Hb levels.
However, this is only the beginning: Further studies are crucial to understand whether donors identified by this algorithm can indeed donate safely under these circumstances. Future work will refine the model, integrate data on iron stores and recovery as well as donor characteristics, and evaluate long-term donor health outcomes.
I am proud to contribute to this international collaborative effort, very efficiently done by Amber Meulenbeld, in memory of Mart Janssen, aimed at enhancing both donor safety and blood supply sustainability.”
Quoting Amber Meulenbeld‘s post:
”If Hb deferral rates are a challenge in your blood establishment, our new study offers a promising new approach! Just published open access in Vox Sanguinis.
By using historical mean Hb levels to assess donor eligibility, we found that deferral rates could drop by up to 70%.
This method also flags donors with consistently low Hb levels who currently pass eligibility due to one-off high readings. That’s a potential safety issue we should start addressing.
This is an early but important step toward incorporating individual histories in donor screening, and I’m curious to see how this develops further!
Another fruitful collaboration of the SanguinStats group, with special thanks to Claire Styles, Glen Shuttleworth, Supun Manathunga, Hans Van Remoortel, Lucile Malard, Tinus Brits, Ronel Swanevelder, José Antonio García Erce, Iris Garcia-Martínez, Surendra Karki (PhD, Epidemiology), Marijke Welvaert, Alton Russell, PhD, Mikko Arvas, Katja van den Hurk, Mart Pothast, and Mart Janssen.”
Title: Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries
Authors: Amber Meulenbeld, Claire Styles, Glen Shuttleworth, Supun Manathunga, Hans van Remoortel, Lucile Malard, Tinus Brits, Ronel Swanevelder, Jose Antonio García-Erce, Iris Garcia-Martínez, Surendra Karki, Marijke Welvaert, W. Alton Russell, Mikko Arvas, Katja van den Hurk, Mart Pothast, Mart Janssen
Read the full article here.
Stay updated with Hemostasis Today.
-
Oct 29, 2025, 10:39UMR1011 Researchers at ECTH 2025
-
Oct 28, 2025, 14:27Maha Othman on 10-Year Anniversary of the CanVECTOR Research Network!
-
Oct 28, 2025, 14:00Claudio Laudani on PCSK9 Association with Increased Platelet Reactivity: A Pooled Analysis
-
Oct 28, 2025, 13:31Laurent Bertoletti Invites You to The INNOVTE and GITA Joined Meeting on Hormones and Thrombosis
-
Oct 28, 2025, 12:28Courtney Lawrence: Honored to Team Up with BET on Blood at AABB 2025
-
Oct 28, 2025, 13:09Gregory Piazza on CORONA-VTE Network Analysis
-
Oct 27, 2025, 18:42Khaled Musallam Shares BEYOND Trial Phase 2 Insights on Luspatercept Use in NTD β-Thalassaemia
-
Oct 27, 2025, 13:30Fabrice Cognasse: When Platelets Meet Artificial Intelligence!
-
Oct 27, 2025, 13:00Hossam El Benawi Shares Multi Site LVT Study from Mayo Clinic
-
Oct 27, 2025, 09:16Prof. Frank Leebeek: About 20 % of People with Von Willebrand's Disease Have Something Strange Going On
-
Oct 27, 2025, 09:19Mitra Najafi: Digital Storage Device - Specifically Designed and Developed to Store and Preserve PRP
-
Oct 25, 2025, 07:42Adithya Hande: India’s Silent Killer and a Scientific Breakthrough
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 27, 2025, 15:10David McIntosh: Making Measurable Progress – Towards a World in Which No-one Ever Dies from Lack of a Vital Plasma-Derived Medicine
-
Oct 27, 2025, 13:18Stroke Foundation Welcomes Jacqui McCallum as the New Executive Director
-
Oct 27, 2025, 12:54Guillermo Lahera Forteza on Stroke and Mental Health
-
Oct 27, 2025, 12:37Joshua Ngimbwa Recognised as the Best Male Junior Investigator Awardee at the Tanzania Health Summit
-
Oct 27, 2025, 09:22Dr. Zsuzsa Bagoly Presents an Overview with Famous People that Suffered from a Stroke